Founder

David is the Founder of Remedium Capital Limited and a Director of AIM4ALL (Services) Limited.

Prior to his current activities, he led two strategic initiatives in the field of alternative R&D financing; in collaboration with ICON plc, as an externalised drug development partner, and Covance, Inc., as an early thought leader in the use of bond financing to fund large portfolios of late-stage drug development programs.

In his early career, David served as a Healthcare Corporate Financier; as a Managing Director of Donaldson, Lufkin & Jenrette / CSFB (Europe) and, prior to that, as a Director of Kleinwort Benson, advising a broad range of pharmaceutical and biopharmaceutical companies and including some of the first listings of European biotechnology companies.

david.hawkins@remediumcapital.com